Rhinelander / Monroe / Vallejo / Louisville / Helsinki / Baltimore / New York / Madison / Lake Forest / Philadelphia / Portland / Cleveland / Detroit / Goodlettsville / St. Louis / /
Company
AEs / Galderma Laboratories LP. / L’Oréal USA / ITT / Galderma R&D / Schering-Plough / Johnson & Johnson Consumer Products Inc / P5.018 / P5.02 / /
Continent
North America / /
Country
Puerto Rico / France / United States / /
Currency
pence / / /
Event
FDA Phase / Natural Disaster / /
Facility
Beth Israel Medical Center / University of Louisville / St. Luke’s-Roosevelt Hospital Center / /
IndustryTerm
treatment / parallel / daily sunlight energy level / treatment groups / methanol solutions / potential products / /
St. Luke’s-Roosevelt Hospital Center / University of Louisville / US Food and Drug Administration / Beth Israel Medical Center / /
Person
Susan Whitmore / Lubomira Scherschun / Bruce H. Miller / Michel Poncet / Lawrence C. Parish / Robert J. Glinert / Francisco Tausk / Scott Clark / Christian Loesche / Ciro Martins / Michael P. Heffernan / Sophia Antipolis / Van Marck / Harold F. Farber / H. Wan-Peng Lim / David Cox / Keith H. Loven / Mark A. Berk / Warwick Morison / Neil Korman / DeLeo / Van Weelden / Lambert JR / Joseph Fowler / Arch Dermatol Res / Karl R. Beutner / Soto Polymorphous / Yu Chen / Hussein Nousari / Pascale Soto Polymorphous / Michelle L. Cihla / Vincent A. DeLeo / / /
Position
Prime Minister / specifically trained study nurse / consultant / consultant and investigator / nurse / Farr PM / Diffey BL / /
Product
triad / Violation / Other / avobenzone / ecamsule / United States / /
ProvinceOrState
Kentucky / Ohio / Wisconsin / Maryland / Illinois / New York / Michigan / Missouri / Tennessee / Pennsylvania / California / Colorado / /